Requests for a “China medical device regulations PDF” usually hide three different needs: the text of the core regulation, the implementing rules for registration, or the catalogues and guidelines that tell you how a rule is applied. They are not interchangeable, and they do not all come from the same place. This guide shows which official texts exist, where to download them, and how to check that the copy on your desk is still in force.
1. What people usually mean by “China medical device regulations PDF”
Some teams want the administrative regulation adopted by the State Council. Others want the departmental rule that governs registration and filing. Others again are looking for the classification catalogue, clinical evaluation guidelines or an official English translation they can circulate internally. Each has a different publisher and a different legal weight, so the first step is to name the document you actually need.
2. The two foundational texts
Two instruments define the framework for medical device market access. Both were published in 2021 and both are listed as currently effective in official databases, but you should re-check the status before each submission because implementing announcements and catalogues are updated far more often than the texts themselves.
| Text | Issuer & number | Published / effective | Role |
|---|---|---|---|
| Regulations on the Supervision and Administration of Medical Devices 医疗器械监督管理条例 | State Council Decree No. 739 | Published 9 February 2021; effective 1 June 2021 | Administrative regulation. Establishes the registrant / filing-holder system, risk-based classification and lifecycle oversight. |
| Provisions for Medical Device Registration and Filing 医疗器械注册与备案管理办法 | SAMR Decree No. 47 | Issued 26 August 2021; effective 1 October 2021 | Departmental rule. Sets out registration and filing procedures, dossier basics and the obligations of overseas applicants. |
Note that the same Chinese regulation appears in English under several titles — “Regulations on the Supervision and Administration of Medical Devices”, “Regulations on Supervision and Administration of Medical Devices”, and even “Measures for the Administration of Registration and Recordation of Medical Devices” for Decree No. 47 in some commercial databases. If a PDF’s English title differs from the one you expect, check the decree number and the effective date rather than assuming it is a different law.
3. The hierarchy below the two texts
3.1 Administrative regulations and departmental rules
Decree No. 739 sets the statutory framework. Decree No. 47 implements it for registration and filing; a companion rule, SAMR Decree No. 48, covers in vitro diagnostic reagents. Where a product is an IVD, both the device framework and the IVD-specific rules may need to be considered — an area where case-specific confirmation is essential.
3.2 Announcements, catalogues and classification documents
The Rules for Classification of Medical Devices (CFDA Decree No. 15, effective 1 January 2016) sets out how risk classes are determined; an official English text is published by the NMPA. The Medical Device Classification Catalogue was released under Announcement No. 104 of 2017 and took effect on 1 August 2018, with implementation details in Notice No. 143 of 2017. The catalogue is subject to adjustment, so a dated PDF is a snapshot, not a permanent answer.
3.3 Technical guidelines and standards
NMPA and its technical institutions publish guidance on dossier structure, clinical evaluation, product technical requirements and testing. These documents shape how a submission is prepared even though they sit below the decrees in the hierarchy. They are also the most frequently updated layer.
4. Where to obtain the official PDFs
- SAMR laws and regulations database — searchable official records that show a text’s effectiveness status, issuing body, publication date and effective date, with text and PDF download. Start here when you need to prove a rule is current.
- SAMR official page for Decree No. 47 — full Chinese text with an official PDF download.
- State Council / gov.cn — the published text of Decree No. 739 and the State Council Gazette version.
- NMPA English site — official English texts of selected rules, plus English announcements and regulatory information.
The full links are listed under Official sources below. All of them are regulator or government-operated domains.
5. What an English translation can and cannot do
The NMPA publishes official English versions of some instruments — including the registration and filing rules and the classification rules — on its English site. These are useful for internal alignment with colleagues who do not read Chinese. Separately, commercial libraries collect English translations of Chinese regulations; they are convenient, but their holdings often include drafts, superseded rules and documents issued under earlier agency names. We have seen collections where a 2018 draft amendment sits alongside a 2014 registration rule, with nothing on the page to distinguish them.
For submission purposes, the Chinese original published by the authority is the controlling text. SAMR Decree No. 47 also requires registration and filing materials to be in Chinese and, where material has been translated from a foreign language, the original to be provided alongside it. A working English copy therefore supports planning; it does not replace the source text.
6. A four-step verification routine
- Identify the document by Chinese title and number, not by a search result title.
- Confirm status in the SAMR database: currently effective, amended, or repealed.
- Check the surrounding layer: implementing announcements, classification adjustments, exemption catalogues and current guidelines can change how the rule applies to a product.
- Document the check with a date and a link, so the next person reviewing the file can repeat it.
For clause-level reading of the registration rule itself, see Provisions for Medical Device Registration and Filing (SAMR Decree No. 47). For the institution behind these documents, see China FDA vs NMPA.
7. What this means for an overseas manufacturer
Three consequences follow. First, build the submission dossier in Chinese and keep the source-language originals of translated evidence. Second, do not treat a statutory review clock as a project schedule: the regulation sets timeframes for defined review steps, while end-to-end duration depends on classification, testing, clinical evaluation and any supplementary information requested — we deliberately do not quote a general approval timeline. Third, make your China legal agent responsible for maintaining a current source library, because announcements and guidance change between formal revisions of the decrees. The NMPA announcements and guidance tracker describes a practical way to organise that work.
Frequently asked questions
QIs there an official English PDF of Decree No. 739?
The authoritative text is the Chinese version published by the State Council and the NMPA. The NMPA English site publishes laws, regulations and regulatory information in English, and its coverage changes over time; check the official English portal for current availability. We would not treat a third-party English PDF as the controlling text.
QAre Decree No. 739 and Order No. 47 still in force?
Official databases list both as currently effective, and official documents issued in 2026 continue to cite them as the framework for registration and filing. Implementing announcements, catalogues and guidelines are revised more frequently, so confirm the status of each text again in the official database before you rely on it for a submission.
QCan we rely on an English translation when preparing a submission?
Use it for planning and internal alignment, but confirm requirements against the Chinese original and current guidance. SAMR Decree No. 47 requires registration and filing materials to be in Chinese and requires the original document to be supplied alongside material translated from a foreign language.
QWhere do we find the classification catalogue?
The Medical Device Classification Catalogue was released under Announcement No. 104 of 2017 and took effect on 1 August 2018, with implementation details in Notice No. 143 of 2017. It is subject to adjustment, so check the NMPA site for the current version and any classification determination documents relevant to your product.
QDo the review timeframes in the regulation tell us how long registration takes?
No. The regulation sets timeframes for specific procedural steps. Overall project duration depends on classification, testing, clinical evaluation, dossier quality and any request for supplementary information. We do not publish a generic timeline, fee or approval rate.
Official sources
The following links point to regulator or government-operated sites. Chinese originals are the authoritative texts; English materials are working references. Check the current version before relying on any document in a submission.
- SAMR laws and regulations database — Decree No. 739 record — Shows effectiveness status, publication and effective dates, with text/PDF download.
- State Council / gov.cn — Regulations on the Supervision and Administration of Medical Devices — Official Chinese text of State Council Decree No. 739.
- State Council Gazette — Decree No. 739 — Gazette version of the decree, published 9 February 2021.
- NMPA — current text of Decree No. 739 — Regulator-hosted text of the administrative regulation.
- SAMR — Provisions for Medical Device Registration and Filing — Full Chinese text of Decree No. 47 with download options.
- SAMR — official PDF of Decree No. 47 — Direct official PDF download.
- NMPA English — Provisions for Medical Device Registration and Filing — Official English text, SAMR Decree No. 47, effective 1 October 2021.
- NMPA English — implementation announcement for Decrees No. 47 and No. 48 — Transitional arrangements and the list of documents abolished on implementation.
- NMPA English — Rules for Classification of Medical Devices (Decree No. 15) — Official English text, effective 1 January 2016.
- NMPA — release of the Medical Device Classification Catalogue — Announcement No. 104 of 2017; effective 1 August 2018.
- NMPA — Notice No. 143 of 2017 on implementing the catalogue — Implementation details and treatment of earlier classification documents.
- NMPA English — Regulatory Information — Official English announcements and policy interpretations.
Working with INTERBRI
INTERBRI helps overseas manufacturers interpret China’s medical device regulations in the context of a specific product and registration pathway: identifying the controlling text, checking its current status, and translating the requirements into a dossier plan. Applicable requirements depend on classification, intended use, place of manufacture and the chosen pathway, and should be confirmed against the current official text for each individual case.
Back to the Regulation Library
